Evaluation of clinical significance of 18F-fluorodeoxyglucose positron emission tomography in superficial squamous cell carcinomas of the thoracic esophagus

Diseases of the Esophagus

Volumn 21, Issue 2, 2008, Pages 144-150

  Miyata, Hiroshi ^a   Doki, Y ^a   Yasuda, T ^a   Yamasaki, M ^a   Higuchi, I ^a   Makari, Y ^a   Matsuyama, J ^a   Hirao, T ^a   Takiguchi, S ^a   Fujiwara, Y ^a   Monden, M ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

FDG PET; Lymphnode metastasis; Submucosal layer; Superficial squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INFILTRATION; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG UPTAKE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MEDICAL DECISION MAKING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; TUMOR VOLUME;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 39049136867     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00743.x     Document Type: Article

References (34)

1. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991; 48: 411-20.
2. Akiyama H, Tsurumaru M, Udagawa H et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994; 220: 364-73.
3. Kato H, Watanabe H, Tachimori Y. Evaluation of neck lymph node dissection for thoracic esophageal carcinoma. Ann Thorac Surg 1991; 51: 931-5.
4. Endo M, Kawano T. Detection and classification of early squamous cell esophageal cancer. Dis Esophagus 1997; 10: 155-8.
5. Kodama M, Kakegawa T. Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 1998; 123: 432-9.
6. Nemoto K, Matsumoto Y, Yamakawa M et al. Treatment of superficial esophageal cancer by external radiation therapy alone: Results of a multi-institutional experience. Int J Radiation Oncol Biol Phys 2000; 46: 921-5.
7. Shioyama Y, Nakamura K, Sasaki T et al. Clinical results of radiation therapy for stage I esophageal cancer: A single institutional experience. Am J Clin Oncol 2005; 28: 75-80.
8. Pech O, Gossner L, May A et al. Endoscopic resection of superficial esophageal squamous-cell carcinomas: Western experience. Am J Gastroenterol 2004; 99: 1226-32.
9. Wieder H A, Brucher B L, Zimmermann F et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004; 22: 900-8.
10. Downey R J, Akhurst T, Ilson D et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: Results of a prospective trial. J Clin Oncol 2003; 21: 428-32.
11. Brucher B L, Weber W, Bauer M et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography. Ann Surg 2001; 233: 300-9.
12. Lerut T, Flamen P, Ectors N et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy. Ann Surg 2000; 232: 743-52.
13. Japanese Society for Esophageal Diseases. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 9th edn, Tokyo: Japanese Society for Esophageal Diseases; 1999.
14. Matsubara T, Ueda M, Abe T, Akimori T, Kokudo N, Takahashi T. Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus. Br J Surg 1999; 86: 669-73.
15. Endo M, Yoshino K, Kawano T, Nagai K, Inoue H. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 2000; 13: 125-9.
16. Shimada H, Nabeya Y, Matsubara H et al. Prediction of lymph node status in patients with superficial esophageal carcinoma. Analysis of 160 surgically resected cancers. Am J Surg 2006; 191: 250-4.
17. Nabeya K, Nagata Y. Extent of resection and lymphadenectomy in early squamous cell esophageal cancer. Dis Esophagus 1997; 10: 159-61.
18. Tachibana M, Yoshimura H, Kinugasa S, Hashimoto N et al. Clinicopathological features of superficial squamous cell carcinoma of the esophagus. Am J Surg 1997; 174: 49-53.
19. Nakajima Y, Nagai K, Miyake S et al. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res 2002; 93: 305-12.
20. Tajima Y, Nakanishi Y, Ochiai A et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma. Cancer 2000; 88: 1285-93.
21. Kato H, Miyazaki T, Nakajima M et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 2005; 103: 148-56.
22. van Westreenen H L, Westerterp M, Bossuyt P M et al. Systematic review of the staging performance of 18f-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004; 22: 3805-12.
23. Kole A C, Plukker J T, Nieweg O E et al. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998; 78: 521-7.
24. Choi J Y, Lee K H, Shim Y M et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 2000; 41: 808-15.
25. Flamen P, Lerut A, Van Cutsem E et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000; 18: 3202-10.
26. Wren SM, Stijns P, Srinivas S. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 2002; 137: 1001-6.
27. Komori T, Doki Y, Kabuto T et al. Prognostic significance of the size of cancer nests in metastatic lymph nodes in human esophageal cancers. J Surg Oncol 2003; 82: 19-27.
28. Kato H, Kuwano H, Nakajima M et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2001; 94: 921-8.
29. Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using (11) C-choline and (18) F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999; 86: 1638-48.
30. Kelly S, Harris K M, Berry E et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 2001; 49: 534-9.
31. Botet J F, Lightdale C J, Zauber A G, Gerdes H, Urmacher C, Brennan M F. Preoperative staging of esophageal cancer: Comparison of endoscopic US and dynamic CT. Radiology 1991; 181: 419-25.
32. Tio T L, Coene P P, Luiken G J, Tytgat G N. Endosonography in the clinical staging of esophagogastric carcinoma. Gastrointest Endosc 1990; 36: S2-10.
33. Murata Y, Niwa Y, Arisawa T, Hase S, Goto H, Hayakawa T. Preoperative staging of superficial esophageal carcinoma: Comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc 1996; 44: 388-93.
34. Greenberg J, Durkin M, Van Drunen M, Aranha G V. Computed tomography or endoscopic ultrasonography in preoperative staging of gastric and esophageal tumors. Surgery 1994; 116: 696-701.